The Latest Global Pharma Industry Monitor Report is Now Available: Including Details...

The Latest Global Pharma Industry Monitor Report is Now Available: Including Details Regarding Recent Mergers, Acquisitions and Major Pharma Deals

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/research/4f5b10/global_pharma_indu)
has announced the addition of the "Global Pharma Industry Monitor"
report to their offering.

The Global Pharma Industry Monitor gives a summary and analysis of
the global pharma market including, mergers, acquisitions,
divestments, major pharma deals and strategic collaborations, clinical
trial highlights, and pipeline advancements occurred in the
April-June, 2008 period. The report contains a brief financial review
and statistical comparison of the quarterly performances of the top
ten pharma companies. It also covers the current scenario and future
trends both at the financial and business levels.

Key Topics Covered:

-Executive Summary

-Mergers, Acquisitions, and Divestments

-Asset Sharing and Licensing Agreements

-Deal Terminations

-Pipeline Expansion and Drug Development Collaborations

-Product Approvals and New Launches

-Drug Approvals, Rejections, and Pipeline Advancements

-Clinical Trial Highlights

-Financial Health Review of the Leading Pharma Companies

-Global Pharma Industry Outlook

Companies Mentioned:

- Actavis

-Astra Zeneca

-Astellas

-Alcon

-Allergan

-Bristol-Myers Squibb

-Daiichi Sankyo

-Eli Lilly

-EisaiForest Laboratories

-JNJ

-GSK

-Merck

-Millenium

-Novartis

-Mylan

-Pfizer

-Ranbaxy

-Schering Plough

-Sepracor

-Takeda

-Teva

-Valeant

-Watson

For more information visit
http://www.researchandmarkets.com/research/4f5b10/global_pharma_indu

Research and Markets
Laura Wood, Senior Manager
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
press@researchandmarkets.com

Copyright Business Wire 2008